Print Page  |  Close Window

VYGR

Voyager Therapeutics Inc
Common Stock

$18.71

+0.86
4.82%
Data as of: 04/26/18  4:00 p.m. ET

Corporate Profile

Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system.

Our management team has deep expertise and a track record of building exceptional life science companies.

Learn More